ALISHA ALEXANDER: Open Payments
NPI 1952945784 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 39 payments from 10 companies in 2025. Trend: 2023 $1,867 · 2024 $827 · 2025 $1,205
Food & beverage: $1,088Education: $117
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $371 |
| GENZYME CORPORATION | 8 | $307 |
| GlaxoSmithKline, LLC. | 11 | $286 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Amgen Inc. | 2 | $39 |
| Optinose US, Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $15 |
Products named: DUPIXENT, NUCALA, LIBTAYO, Xhance, KEYTRUDA, ZENPEP, ZEPBOUND, TEZSPIRE.
Industry payments across NV — which companies pay providers there.
